Mural Oncology (NASDAQ:MURA – Get Free Report) had its target price lowered by equities researchers at HC Wainwright from $18 ...

Stock analysts at HC Wainwright decreased their Q1 2025 earnings per share estimates for shares of Rhythm Pharmaceuticals in ...

Fintel reports that on March 27, 2025, HC Wainwright & Co. initiated coverage of RenovoRx (NasdaqCM:RNXT) with a Buy ...

H.C. Wainwright lowered the firm’s price target on Bitfarms (BITF) to $3.50 from $4 and keeps a Buy rating on the shares. The firm also added ...

H.C. Wainwright analyst Joseph Pantginis maintained a Hold rating on Shattuck Labs (STTK – Research Report) today. The company’s shares opened ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Fintel reports that on March 21, 2025, HC Wainwright & Co. downgraded their outlook for OptiNose (NasdaqGS:OPTN) from Buy to ...

Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a ...

Diagnostics' Q4 2024 earnings insights, FDA resubmissions, TB & HPV test pipelines, and international market growth plans.

CEO Steven Rossi emphasized that fiscal year 2024 was a transformative period for Worksport, with net sales reaching $8.4 million, representing a 455% increase from 2023. This growth was primarily ...

On Monday, H.C. Wainwright reaffirmed a Buy rating on Benitec BioPharma (NASDAQ:BNTC) shares, maintaining a $28.00 price target. The stock has shown remarkable momentum, delivering a 225% return over ...

On Monday, H.C. Wainwright reaffirmed a Buy rating on Benitec BioPharma (NASDAQ:BNTC) shares, maintaining a $28.00 price target. The stock has shown remarkable momentum, delivering a 225% return ...